BS PHARM KOREA Partners with Dongkook Pharmaceutical for INHILO+
BS PHARM KOREA Announces Strategic Partnership with Dongkook Pharmaceutical for INHILO+
BS PHARM KOREA is proud to announce a strategic partnership with Dongkook Pharmaceutical for the domestic distribution of INHILO+, our Dual HA Skin Booster.
This partnership marks an important milestone in expanding INHILO+ within the Korean medical aesthetics market, combining BS PHARM KOREA’s product expertise with Dongkook Pharmaceutical’s established domestic distribution network.
Through this collaboration, BS PHARM KOREA aims to strengthen product accessibility, build greater market confidence, and further expand its presence in the professional aesthetic field.
As demand for skin quality-focused aesthetic treatments continues to grow worldwide, this collaboration further reinforces confidence in innovative Korean aesthetic solutions and highlights the increasing recognition of advanced skin booster technologies in the domestic market.
Why INHILO+?
INHILO+ was developed to support skin hydration, skin quality improvement, and overall skin revitalization through a balanced Dual HA approach.
Unlike conventional single-component formulations, INHILO+ combines both High Molecular Weight Hyaluronic Acid (H-HA) and Low Molecular Weight Hyaluronic Acid (L-HA), allowing the formulation to support hydration across multiple skin layers.
Key Features of INHILO+
- – Dual HA Technology (High HA + Low HA)
- – 48mg Cross-Linked Hyaluronic Acid
- – Skin Hydration Support
- – Skin Barrier Enhancement
- – Skin Bioremodeling Approach
- – Suitable for Multiple Treatment Areas
The integration of different molecular weights enables a more comprehensive hydration strategy while helping maintain healthy-looking skin and supporting skin quality improvement.
As the global aesthetic market increasingly shifts toward prevention-focused and skin quality-centered treatments, Dual HA technology continues to gain attention among aesthetic professionals.
Expanding Innovation Across Multiple Aesthetic Categories
At BS PHARM KOREA, innovation extends beyond a single product category. The company continues to develop and expand a diverse portfolio of dermal fillers and skin booster solutions based on a wide range of aesthetic ingredients and technologies, including:
- – Hyaluronic Acid (HA)
Widely utilized in dermal fillers and hydration-focused skin boosters to support skin moisture and improve skin appearance. - – PN & PDRN
Ingredients increasingly recognized for their role in supporting skin revitalization and tissue recovery-focused aesthetic approaches. - – Exosome-Based Technologies
Advanced ingredient platforms designed to support next-generation skin quality management strategies. - – Peptide Complexes
Formulations developed to complement skin conditioning and rejuvenation-focused treatments. - – NAD+ & Cellular Energy-Based Ingredients
Emerging technologies aligned with the growing global interest in longevity, skin vitality, and cellular-focused aesthetic solutions.
Through continuous research, product development, and global market expansion, BS PHARM KOREA is committed to providing innovative aesthetic solutions that address evolving market needs while supporting aesthetic professionals worldwide.
Recognition Through Strategic Collaboration
The selection of INHILO+ for domestic distribution reflects the growing demand for advanced skin quality solutions within the Korean aesthetic market. Strategic collaborations between manufacturers and established pharmaceutical companies play an important role in bringing innovative technologies to a broader audience while ensuring product accessibility and professional support.
For BS PHARM KOREA, this partnership represents not only a commercial milestone but also recognition of the company’s ongoing commitment to product quality, innovation, and long-term market development. As the aesthetic industry continues to evolve, partnerships built on trust, expertise, and innovation will remain essential in delivering meaningful value to practitioners and patients alike.
Looking Ahead
BS PHARM KOREA remains focused on expanding its global footprint through continuous innovation, strategic partnerships, and the development of advanced aesthetic solutions. With a growing portfolio spanning Dual HA Skin Boosters, PN & PDRN-based products, Exosome technologies, Peptide formulations, NAD+ solutions, and Dermal Fillers, the company continues to strengthen its position within the global medical aesthetics industry.
We look forward to creating new opportunities with partners worldwide while delivering innovative solutions designed to meet the evolving needs of modern aesthetic practice.
Frequently Asked Questions (FAQ)
What is INHILO+?
INHILO+ is a Dual HA Skin Booster formulated with both High Molecular Weight Hyaluronic Acid and Low Molecular Weight Hyaluronic Acid to support skin hydration and skin quality improvement.
What makes Dual HA technology different?
Dual HA formulations combine different molecular weights of hyaluronic acid, allowing hydration support across multiple skin layers while helping maintain healthy-looking skin.
Why is the partnership with Dongkook Pharmaceutical significant?
Dongkook Pharmaceutical is one of Korea’s established pharmaceutical companies with a strong distribution network. The partnership supports broader market access for INHILO+ and reflects confidence in the product’s market potential.
What aesthetic product categories does BS PHARM KOREA develop?
BS PHARM KOREA develops a broad portfolio including Dermal Fillers, Skin Boosters, PN & PDRN-based products, Exosome solutions, Peptide formulations, NAD+ technologies, and HA-based aesthetic products.
Learn More About INHILO+
Discover more about INHILO+, BS PHARM KOREA’s Dual HA-based aesthetic solution designed with a balanced hyaluronic acid formulation. For product details, specifications, and related information, please visit the INHILO+ product page.
Contact BS PHARM KOREA
For business inquiries, product information, or partnership opportunities, please contact the BS PHARM KOREA team. We look forward to connecting with aesthetic professionals, distributors, and business partners worldwide.
